US President Trump's 25% tariff plan on pharmaceuticals jeopardizes Indian pharma exports, making generics pricier and ...

Amphastar Pharmaceuticals has a growth model based on organic growth and acquisitions, though competition and patent ...

Any potential US tariffs on Indian pharmaceutical exports could primarily affect American consumers, as stated by Pharmexcil. With India sending over USD 8 billion worth of generic drugs annually, ...

Discover how Medifast navigates GLP-1 market shifts with innovative products like OPTAVIA ASCEND, cost-saving initiatives, and growth strategies for 2025.

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

BMS is not the only U.S. pharma giant making massive cuts. Last year, Pfizer revealed a similar plan to reduce costs by an additional $1.5 billion through 2027. That initiative came after the ...

“That must be a factor as pharma companies are deciding on whether to pursue big events, including the Super Bowl.” The top barrier to entry for pharma brands considering a marketing play ... and ...

Despite the challenges, there appears to be huge opportunities for marketing excellence in pharma -- if companies are willing to harness innovative new strategies, break down silos and introduce ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...